## 

|Contents||Pages|
|---|---|---|
|Legal and administrative<br>information|||
|Trustees<br>report||2-6|
|Independent<br>Examiner's<br>Report|||
|Statement offinancial|activities||
|Statement offinancial|activities (31 March 2022)||
|Balance sheet||10|
|Notes to the financial|statements|11- 19|





## 



## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 



## 

## 

## 



## 




## 

## 

## 

## 



## 

## 

||||Unrestricted|Restricted|Total funds|Total funds|
|---|---|---|---|---|---|---|
|||Note|funds|funds|2023|2022|
|Income and expenditure|||||||
|Income|||||||
|Donations<br>and legacies|||18,043|159,663|177,706|158,589|
|Investment<br>income|||205|7,875|8,080|716|
|Total income|||18,248|167,538|185,786|159,305|
|Expenditure|||||||
|Cost of raising funds|||12,605|73,333|85,938|119,731|
|Charitable<br>activities|||10,674|383,985|394,659|137,535|
|Total expenditure|||23,279|457,318|480,597|257,266|
|Net expenditure|||(5,031)|(289,780)|(294,811)|(97,961)|
|Net movement<br>in funds|||(5,031)|(289,780)|(294,811)|(97,961)|
|Fund balances|||||||
|Balances brought|forward||55,353|847,998|903,351|1,001,312|
|Balances carried forward|||50,322|558,218|608,540|903,351|





## 

## 

||||Unrestricted|Restricted|Total funds|Total funds|
|---|---|---|---|---|---|---|
|||Note|funds|funds|2022|2021|
||||F|F|||
|Income and expenditure|||||||
|Income|||||||
|Donations<br>and legacies|||27,056|131,533|158,589|268,062|
|Investment<br>income|||716||716|2,353|
|Total income|||27,772|131,533|159,305|270,415|
|Expenditure|||||||
|Cost of raising funds|||8,576|111,155|119,731|145,183|
|Charitable<br>activities|||15,319|122,216|137,535|29,222|
|Total expenditure|||23,895|233,371|257,266|174,405|
|Net expenditure|||3,877|(101,838)|(97,961)|96,010|
|Net movement<br>in funds|||3,877|(101,838)|(97,961)|96,010|
|Fund balances|||||||
|Balances brought|forward||51,476|949,836|1,001,312|905,302|
|Balances carried forward|||55,353|847,998|903,351|1,001,312|





## 

## 

|Current assets||||||
|---|---|---|---|---|---|
|Debtors||||1,493|248|
|Bank balances<br>and|cash in hand|||678,096|944,984|
|||||679,589|945,232|
|Creclitois: amounts|fatling due within one year|||(71,049)|(41,881)|
|Total asselm less current||liabilities|||903,351|
|Unrestdcted<br>funds|||12|50,322|M,3S3|
|Restricted funds|||12|558,218|847,998|
|Total funds|||||903,351|





## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

|||||2023|2022|
|---|---|---|---|---|---|
|General donations||||49,630|24,745|
|Legacies|||||38,814|
|Donations|from charitable||trusts|128,076|78,082|
|Donations|from events||||16,948|
|||||177,706|158,589|
|Restricted|income is6159,663(2022:F131,533).|||||
|Interest receivable and similar income||||||
|||||2023|2022|
|Interest receivable||||8,080|716|
|Restricted|income is E7,875(2022: Nil).|||||
|Costs of raising funds||||||
|||||2023|2022|
|Direct costs offund raising activities||||8,544|4,508|
|Staff costs||||67,092|100,051|
|General overheads||||10,302|15,172|
|||||85,938|119,732|
|Restricted|expenditure|is F73,333(2022:F111,155).||||





## 

## 

|Not|es to the|financial statements<br>for the year e|financial statements<br>for the year e|nded 31 March 202|3 (continu|
|---|---|---|---|---|---|
|6.|Charitable|activities||||
|||||2023|2022|
||Medical salaries and direct costs|||347,319|122,216|
||Staff costs|||33,589|1,021|
||General overheads|||6,560|3,046|
||Governance||costs (note 7)|7,191|11,252|
|||||394,659|137,535|
|Restricted<br>expenditure|||is 6384,005(2022:F122,216).|||
|7.|Governance||costs|||
|||||2023|2022|
||Staff costs|||666|1,021|
||Independent||examination|4,317|7,210|
||Other costs|||2,208|3,021|
|||||7,191|11,252|
|8.|Staff costs|||||
|||||2023|2022|
||Staff:|||||
||Gross|||61,482|60,413|
||Employers|Nl||7,578|7,015|
||Pension|||9,537|8,665|
||Self-employed:|||||
||Gross|||22,570|26,000|
|||||101,167|102,093|





## 

## 

|Not|es to the|financial statements<br>for the ye|ar ended 31 March 20|23 (continu|
|---|---|---|---|---|
|9.|Debtors||||
||||2023|2022|
||Due within one year||||
||Interest receivable||1,228|149|
||Other debtors and prepayments||265|99|
||||1,493|248|
|10.|Creditors||||
||||2023|2022|
||Due within one year||||
||Deferred|income|||
||Other creditors and accruals||71,049|41,881|
||||71,049|41,881|
|11.|Deferred|income|||
||||2023|2022|
||Brought forward|||2,781|
||Movement|||(2,781)|
||Carried forward||||
|12.|Analysis|ofnet assets between funds|||
||||Net current|Net current|
||||assets|assets|
||||2023|2022|
||General<br>fund||50,322|55,353|
||Restricted|funds (note 13)|558,218|847,998|
||||608,540|903,351|





## 

## 

## 

## 

|Restricted funds||||||||||
|---|---|---|---|---|---|---|---|---|---|
|||||||Balance|||Balance|
|2023||||||1 April|||31 March|
|||||||2022|Income|Expenditure|2023|
|Aids||||||600|||600|
|Arthritis<br>(Dr Fisher's<br>RLHH||||||||||
|Research)|||||2|14,057|644|9,000|5,701|
|Cancer Clinical Trials|||||3|698|213||911|
|Cancer Day Centre|||||4|200,006|1,059|200,000|1,065|
|Cardiology<br>Clinical Trials|||||5|3,139|||3,139|
|Colorectal<br>Cancer Unit|||||6|4,283|72|1,000|3,355|
|COX2 Sarcoid<br>Project|||||7|1,137|||1,137|
|Dr Seddon's Sarcoma|Fund||||8|137,161|24,824|15,000|146,985|
|Early Lung Cancer Project|||||9|927|247|1,000|174|
|Learning<br>Disability Services|||||10|77|||77|
|Lifebox|||||11|46|||46|
|Lung 8 Heart Bioresource|||||12|236,023|840||236,023|
|Lungs For Living|||||13|170,732|37,732|128,350|80,114|
|The Michael Feldman|8 Lady|||Estelle||||||
|Wolfson Bursary Fund|||||14|11,178|100,608|96,513|15,273|
|Mitochondrial<br>Fund|||||15|21,785|215|3,000|19,000|
|Multi-sensory<br>Room|||||16|1,000|||1,000|
|Paediatric<br>Oncology Research||||Nurse|17|451|||451|
|Paediatric Ward T11|||||18|2,279|6||2,285|
|Pranav Pandya's<br>Obstetrics|||Fund||19|18,177|323|2,000|16,600|
|Radiopharmacy<br>Facility|||||20|367|||367|
|RLHH|||||21|908|||908|
|RLHH Research|||||22|1,058|72|1,000|130|
|RNTNE Play Services|Fund||||23|25|||25|
|Roald Dahl Fund|||||24|192|||192|
|Rokitansky<br>Syndrome|Fund||||25|299|||305|
|Royal Nat. Throat Ear|&Nose|||||||||
|Hospital|||||26|333|||333|
|Sarcoid|||||27|830|454||1,284|
|Severe Asthma<br>Unit|||||28|42|||42|
|Stephen<br>Green Fund|||||29|2,724|72|1,000|1,796|
|Therapy Services|||||30|200|||200|
|Transplant<br>Unit|||||31|930|||930|
|UCLH Paediatric<br>Epilepsy||Unit|||32|15,004|143|2,000|13,147|
|Young People's<br>Unit|||||33|1,230|8|(2,545)|3,783|
|||||||847,998|167,538|457,318|558,218|





## 

## 

## 

## 

|||||||Balance|||Balance|
|---|---|---|---|---|---|---|---|---|---|
|2022||||||1 April|||31 March|
|||||||2021|Income|Expenditure|2022|
|Aids||||||600|||600|
|Arthritis<br>(Dr Fisher's<br>RLHH||||||||||
|Research)|||||2|15,203||1,146|14,057|
|Cancer Clinical Trials|||||3|578|120||698|
|Cancer Day Centre|||||4|249,165|93|49,252|200,006|
|Cardiology<br>Clinical Trials|||||5|20,328||17,189|3,139|
|Colorectal<br>Cancer Unit|||||6|5,452||1,169|4,283|
|COX2 Sarcoid<br>Project|||||7|2,283||1,146|1,137|
|Dr Seddon's Sarcoma|Fund||||8|123,307|15,000|1,146|137,161|
|Early Lung Cancer Project|||||9|827|100||927|
|Learning<br>Disability Services|||||10|77|||77|
|Lifebox|||||11|46|||46|
|Lung 8 Heart Bioresource|||||12|232,523|3,500||236,023|
|Lungs For Living|||||13|207,125|53,424|89,817|170,732|
|The Michael Feldman|Bursary|||Fund|14|35,340|40,000|64,162|11,178|
|Mitochondrial<br>Fund|||||15|22,931||1,146|21,785|
|Multi-sensory<br>Room|||||16|1,000|||1,000|
|Paediatric<br>Oncology Research||||Nurse|17|1,597||1,146|451|
|Paediatric Ward T11|||||18|2,279|||2,279|
|Pranav Pandya's<br>Obstetrics|||Fund||19|18,177|100||18,277|
|Radiopharmacy<br>Facility|||||20|1,513||1,146|367|
|RLHH|||||21|908|||908|
|RLHH Research|||||22|1,058|||1,058|
|RNTNE Play Services|Fund||||23|25|||25|
|Roald Dahl Fund|||||24|192|||192|
|Rokitansky<br>Syndrome|Fund||||25|299|||299|
|Royal Nat. Throat Ear|&Nose|||||||||
|Hospital|||||26|333|||333|
|Sarcoid|||||27|1,711|265|1,146|830|
|Severe Asthma<br>Unit|||||28|42|||42|
|Stephen<br>Green Fund|||||29|2,724|||2,724|
|Therapy Services|||||30|200|||200|
|Transplant<br>Unit|||||31|930|||930|
|UCLH Paediatric<br>Epilepsy||Unit|||32||16,150|1,146|15,004|
|Young People's<br>Unit|||||33|1,063|2,781|2,614|1,230|
|||||||949,836|131,533|233,371|847,998|





## 

## 

## 

|Restricted funds<br>(continued)|Restricted funds<br>(continued)|Restricted funds<br>(continued)|||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|Notes|||||||||||||
|(1.)|These funds|are for research<br>into HIV/AIDS|||||||||||
|(2.)|These funds|are to support|research<br>and educational<br>work regarding|||Arthritis||at|the Royal|||London|
||Homoeopathic|Hospital<br>(now known as the Royal London<br>Hospital|||for|Integrated|||Medicine)||||
|(3.)|These funds are to support||the Cancer Clinical Trials Unit (primarily||Gl)||||||||
|(4.)|These funds are for the UCH Macmillan<br>Cancer Centre||||||||||||
|(5.)|These funds are to support||research work into Cardiology||||||||||
|(6.)|These funds|are to provide|equipment<br>and patient<br>information|packs for the Colorectal||||||||Cancer|
||Unit||||||||||||
|(7.)|These funds|are to support|the COX2 Sarcoid project||||||||||
|(8.)|These funds|are to support|Dr Seddon's Sarcoma Fund||||||||||
|(9.)|These funds|are to support|the Early Lung Cancer Detection 8 Treatment||||Programme||||||
|(10.)|These funds are to support||Learning<br>Disability Services throughout||the|Trust|||||||
|(11.)|These funds|are for Lifebox|||||||||||
|(12.)|These funds|are to support|the UCLH Lung 8 Heart Bioresource||||||||||
|(13.)|These funds|are to support|Lungs for Living||||||||||
|(14.)|These funds|are to support|the Stroke Services Department<br>at UCLH||||||||||
|(15.)|These funds|are to support|Mitochondrial<br>Research||||||||||
|(16.)|These funds|are to support|a multi-sensory<br>room||||||||||
|(17.)|These funds|were used to support a Paediatric Oncology Research Nurse and research|||||||||work into||
||Paediatric<br>Oncology||||||||||||
|(18.)|These funds|are to provide|recreational<br>facilities for the T11 Paediatric Ward||||||||||
|(19.)|These funds|are to support|the Obstetrics<br>work of Pranav Pandya||and the Fetal|||||Medicine||Unit|
|(20.)|These funds|are for a Radiopharmacy<br>Facility|||||||||||
|(21.)|These funds|are for the complementary<br>and alternative<br>medicine|||library||and|information|||centre at||
||the Royal London Homoeopathic<br>Hospital<br>(now known as the Royal London|||||||Hospital for Integrated|||||
||Medicine)||||||||||||
|(22.)|These funds|are for research carried out at Royal London Homoeopathic|||||Hospital|||(now known as|||
||the Royal London<br>Hospital||for Integrated<br>Medicine)||||||||||
|(23.)|These funds|are to support|the Roald Dahl Marvellous<br>Children's||Charity Play Specialist||||||||





## 

## 

## 

## 

## 

